1. #biotech #buy #stocks $OCRX $EVOK $IMMU $OPXA $OXGN $ACST $ONTX $CYCC $SPHS $CYTR $CPRX $ADXS and others http://www.michele-ciani.com/StockTrader/Stocks.html

  2. #biotech #buy #stocks $OCRX $ECYT $IMMU $SGYP $SPHS $CPRX $VSTM $RPRX $MSTX $EVOK $ONTX $CYCC and others http://www.michele-ciani.com/StockTrader/Stocks.html

  3. $CYCC Likey

  4. #biotech #buy #stocks $OCRX $IPCI $OREX $HRTX $CLDX $VSTM $ALXA $ACST $ABIO $ECYT $CPHI $CYCC and others http://www.michele-ciani.com/StockTrader/Stocks.html

  5. $CYCC founder Sir David Lane p53 + $SQNM Dennis Lo together@ #SCC2014 SYDNEY CANCER CONFERENCE Keynote speakers http://sydney.edu.au/cancer-research/SCC2014/speakers/index.php … …

  6. $CYCC insider started a buy yesterday - small but a start - looking for more Form 4s in the next days

  7. $CYCC insiders buy at this level

  8. Strong buy... $NBS / $GALE / $CYCC

  9. $CYCC Nice, an insider buy, first since May 2013.

  10. Cyclacel Pharmaceuticals Director Sam Barker Buys $9,300 in $CYCC http://www.analystratings.net/stocks/NASDAQ/CYCC/?RegistrationCode=SocialMedia-direct&DefaultTab=Insider

  11. Insider Transaction: $CYCC Purchase at $3 per share of 3100 shares by Director Barker Sam L on 2014-11-20.

  12. $CYCC strong support in the $2.8 - $2.9. Good opportunity to enter

  13. $CYCC has been granted United States Patent 8,889,861 November 18 2014 - Crystalline forms of a purine derivative …

  14. $CYCC is a buy here

  15. @adamfeuerstein $SNSS (failed Phase3 AML) almost double $CYCC (90%+ Phase 3 AML enrollment) marketcap again

  16. $CYCC related:RT @adamfeuerstein $SNSS PR about #ASH14 late breaker abstract leaves out part about vosaroxin study failing.A minor oversight

  17. $CYCC

  18. Reading answers presented regarding $CYCC conference call transcript http://www.conferencecalltranscripts.org/include/?location=http://seekingalpha.com/article/2671985-cyclacel-pharmaceuticals-cycc-ceo-spiro-rombotis-on-q3-2014-results-earnings-call-transcript

  19. $CYCC Fasttrack....!!!!

  20. @TickrWatch: Cyclacel Pharmaceuticals Shares Escalate on Releasing Smaller Than Expected Loss of $0.22; Tops Revenue As Well $CYCC

  21. Cyclacel Pharmaceuticals Shares Escalate on Releasing Smaller Than Expected Loss of $0.22; Tops Revenue As Well $CYCC

  22. Listen to $CYCC Q3 2014 earnings call - live at 04:30 PM, ondemand after - http://earningscast.com/q3-2014-cyclacel-pharmaceuticals-inc-earnings-conference-call

  23. $CYCC http://www.globenewswire.com/news-release/2014/11/11/682195/10107622/en/Cyclacel-Pharmaceuticals-Reports-Third-Quarter-2014-Financial-Results.html

  24. $CYCC has been granted Patent 8884001 November11 14 Sapacitabine (+production) related … Preparation of intermediates

  25. $CYCC related: $AGIO AG-221 #ASH14 Abstract: One death reported as possibly related to study drug in a subject with severe pneumonia. #AML